buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone]
- RxCUI
- 1010606
- RxNorm name
- buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone]
- Display name
- SUBOXONE (Sublingual)
- Full name
- buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone]
- Term type
- SBD
- Status
- Active
- Strength
- 8-2 mg
- Dose form
- Film
- Route
- Sublingual
- Updated
- 2026-11-19 17:11:45
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 102010
- Active start
- 102010
- Multiple ingredient
- YES
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| buprenorphine hydrochloride | 8 MG / 1 EACH | buprenorphine | buprenorphine |
| naloxone hydrochloride dihydrate | 2 MG / 1 EACH | naloxone | naloxone |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Sublingual Film | 2269578 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| buprenorphine | 1819 |
| naloxone | 7242 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Suboxone 8/2 Sublingual Film | 1 | NAMES |
| RxNorm Name | buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 8a5edcf9-828c-4f97-b671-268ab13a8ecd | 1 | CODES |
| RxCUI | 1010606 | 1 | CODES |
| MMSL_CODE | BD26502 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 12496-1208-3 | 12496-1208 | Suboxone buprenorphine hydrochloride, naloxone hydrochloride | INDIVIOR INC. | NDA022410 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| NDA022410 | 12496-1208 | Suboxone buprenorphine hydrochloride, naloxone hydrochloride | NDA | INDIVIOR INC. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Suboxone | BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE | INDIVIOR INC. | 8a5edcf9-828c-4f97-b671-268ab13a8ecd | 2025-12-22 | Warnings, Adverse reactions | 12496-1208-3 12496-1208 12496120803 12496120801 1010606 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8a5edcf9-828c-4f97-b671-268ab13a8ecd | Suboxone 8 MG / 2 MG Sublingual Film [PSN] · buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone] [SBD] · Suboxone 8/2 (buprenorphine HCl / naloxone HCl dihydrate) Sublingual Film [SY] · Suboxone 8/2 Sublingual Film [SY] | 4 | 37 | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | 20251222 |
| 54c487ac-750b-462e-a4cb-dcab1dd43ba8 | Suboxone 8 MG / 2 MG Sublingual Film [PSN] · buprenorphine 8 MG / naloxone 2 MG Sublingual Film [Suboxone] [SBD] · Suboxone 8/2 (buprenorphine HCl / naloxone HCl dihydrate) Sublingual Film [SY] · Suboxone 8/2 Sublingual Film [SY] | 4 | 4 | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use CIII Initial U.S. Approval: 2002 | 20180531 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 8a5edcf9-828c-4f97-b671-268ab13a8ecd | HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | INDIVIOR INC. | SGS North America Inc. | Aquestive Therapeutics | Alcami Carolinas Corporation | Infinity Labs IN, Inc | Sharp Packaging Services, LLC | SpecGx LLC | Macfarlan Smith Limited | INDIVIOR UK Limited | Butterworth Laboratories Ltd | QUOTIENT SCIENCES (ALNWICK) LIMITED | Siegfried AG | Veranova, L.P. | PPD Development, L.P. | 20260108 |
| 8a5edcf9-828c-4f97-b671-268ab13a8ecd | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | INDIVIOR INC. | Alcami Carolinas Corporation | Aquestive Therapeutics | Butterworth Laboratories Ltd | INDIVIOR UK Limited | Infinity Labs IN, Inc | Macfarlan Smith Limited | PPD Development, L.P. | QUOTIENT SCIENCES (ALNWICK) LIMITED | SGS North America Inc. | Sharp Packaging Services, LLC | Siegfried AG | SpecGx LLC | Veranova, L.P. | 20251222 |
| 8a5edcf9-828c-4f97-b671-268ab13a8ecd | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use, CIII Initial U.S. Approval: 2002 | INDIVIOR INC. | Alcami Carolinas Corporation | Aquestive Therapeutics | Butterworth Laboratories Ltd | INDIVIOR UK Limited | Infinity Labs IN, Inc | Macfarlan Smith Limited | PPD Development, L.P. | QUOTIENT SCIENCES (ALNWICK) LIMITED | SGS North America Inc. | Sharp Packaging Services, LLC | Siegfried AG | SpecGx LLC | Veranova, L.P. | 20251222 |
| 54c487ac-750b-462e-a4cb-dcab1dd43ba8 | These highlights do not include all the information needed to use SUBOXONE sublingual film safely and effectively. See full prescribing information for SUBOXONE sublingual film. SUBOXONE ® (buprenorphine and naloxone) sublingual film, for sublingual or buccal use CIII Initial U.S. Approval: 2002 | Aidarex Pharmaceuticals LLC | Aidarex Pharmaceuticals | 20180531 |
| fef55310-758c-4476-94c2-f022b9ccd5ea | National Council for Prescription Drug Programs | 20120724 | |
| 0e9d2da8-c0b7-4455-84c4-faee2411e5d7 | National Council for Prescription Drug Programs | 20120724 | |
| e5a78b2e-7a07-4283-ab4b-08b8811eecbf | National Council for Prescription Drug Programs | 20120724 | |
| d059304e-cc6b-42ee-8f43-28a9b9fc1c1c | National Council for Prescription Drug Programs | 20120724 | |
| c5d99706-28cc-4ea7-a695-a30460daf1f8 | National Council for Prescription Drug Programs | 20120724 | |
| bb41b50f-03db-41ee-a8cf-671462bf22bc | National Council for Prescription Drug Programs | 20120724 | |
| a4cc81ff-1e11-462e-b7df-6b3062ecfa1e | National Council for Prescription Drug Programs | 20120724 | |
| a086c046-051c-4d65-94bb-81b7475b5c9b | National Council for Prescription Drug Programs | 20120724 | |
| 6a5b7992-ea85-4954-901f-cd6fc347319d | National Council for Prescription Drug Programs | 20120724 | |
| 5b153f64-f646-4582-905c-d168bb3960e1 | National Council for Prescription Drug Programs | 20120724 | |
| 5665ed8b-e752-4552-9ab7-219f10742e99 | National Council for Prescription Drug Programs | 20120724 | |
| 4cdecec6-4c34-433a-9396-55d69bd2131d | National Council for Prescription Drug Programs | 20120724 | |
| 2af28764-29dd-4b89-9dc0-1d241d7f2b4d | National Council for Prescription Drug Programs | 20120724 | |
| 2594bfc2-8dd1-49ea-a1e0-ea1d84da6c16 | National Council for Prescription Drug Programs | 20120724 | |
| 97677ce7-9562-43d0-8b99-8d1f37c1e3c6 | Physicians Total Care, Inc. | 20100727 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | V03AB | Antidotes | ATC1-4 | naloxone | |
| ATC | N07BC | Drugs used in opioid dependence | ATC1-4 | buprenorphine | |
| ATC | N02AE | Oripavine derivatives | ATC1-4 | buprenorphine | |
| ATC | A06AH | Peripheral opioid receptor antagonists | ATC1-4 | naloxone | |
| FDASPL | N0000175691 | Opioid Antagonist | EPC | has_epc | naloxone |
| FDASPL | N0000175689 | Partial Opioid Agonist | EPC | has_epc | buprenorphine |
| FDASPL | N0000000154 | Opioid Antagonists | MOA | has_moa | naloxone |
| FDASPL | N0000175685 | Partial Opioid Agonists | MOA | has_moa | buprenorphine |
| MEDRT | D002047 | Buprenorphine | CHEM | has_ingredient | buprenorphine |
| MEDRT | D009270 | Naloxone | CHEM | has_ingredient | naloxone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naloxone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | buprenorphine |
| MEDRT | D006556 | Heroin Dependence | DISEASE | may_treat | buprenorphine |
| MEDRT | D009293 | Opioid-Related Disorders | DISEASE | may_diagnose | naloxone |
| MEDRT | D009293 | Opioid-Related Disorders | DISEASE | may_treat | naloxone |
| MEDRT | D010146 | Pain | DISEASE | may_treat | buprenorphine |
| MEDRT | D012120 | Respiration Disorders | DISEASE | may_treat | naloxone |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | naloxone |
| MEDRT | N0000000154 | Opioid Antagonists | MOA | has_moa | buprenorphine |
| MEDRT | N0000000154 | Opioid Antagonists | MOA | has_moa | naloxone |
| MEDRT | N0000175685 | Partial Opioid Agonists | MOA | has_moa | buprenorphine |
| MEDRT | N0000175729 | Central Nervous System Stimulation | PE | has_pe | naloxone |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | buprenorphine |
| MEDRT | N0000178478 | Increased Blood Pressure | PE | has_pe | naloxone |
| MEDRT | N0000009393 | Increased Medullary Respiratory Drive | PE | has_pe | naloxone |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 8 MG / 2 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 3 |
| CODES | NDA | NDA022410 |
| NAMES | Prescribable Synonym | Suboxone 8 MG / 2 MG Sublingual Film |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |